Atlas Trials

Compare Neoadjuvant Chemotherapy of DOS Versus SOX in Locally Advanced Gastric Adenocarcinoma.

Clinical trial NCT03691454 · UNKNOWN

Trial details

NCT number
NCT03691454
Sponsor
Peking University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Gastric Adenocarcinoma
Start date
2018-06-28
Primary completion
2022-06-30
Enrollment
258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.